ليست عنوان مقالات لاتين Droplet size and composition of nutraceutical nanoemulsions influences bioavailability of long chain fatty acids and Coenzyme Q10 Dry atmospheric deposition and deposition velocities of dicamba, 2,4-dichlorophenoxyacetic acid and γ-1,2,3,4,5,6-hexachlorocyclohexane Original Research Article

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Droplet size and composition of nutraceutical nanoemulsions influences bioavailability of long chain fatty acids and Coenzyme Q10

2

Droplet size and stability of nano-emulsions produced by the temperature phase inversion method

3

Droplet size and transmittance spectra of mechanically generated water fogs

4

Droplet size and velocity distributions for spray modelling

5

Droplet size control in the filter expansion aerosol generator

6

Droplet size determination in food emulsions: comparison of ultrasonic and light scattering methods

7

Droplet size distribution and evaporation characteristics of fuel spray by a swirl type atomizer

8

Droplet Size Distributions as a function of rainy system type and Cloud Condensation Nuclei concentrations

9

Droplet size measurements in horizontal annular gas–liquid flow

10

Droplet size spectra and drift effect of two phenmedipham formulations and four adjuvants mixtures

11

Droplet sizing using silicone oils

12

Droplet spreading: a tool to characterize surfaces at the microscopic scale

13

Droplet transport in oil/gas and water/gas flow at high gas densities

14

Droplet vaporisation characteristics of vegetable oil derived biofuels at high temperatures

15

Droplet vaporization model in the presence of thermal radiation

16

Droplet vaporization modeling of rapeseed and sunflower methyl esters

17

Droplet-based microdialysis—Concept, theory, and design considerations

18

Droplet-based microextraction in the aqueous two-phase system

19

Droplet-based microfluidic lab-on-a-chip for glucose detection

20

Droplet-based microfluidic lab-on-a-chip for glucose detection Original Research Article

21

Droplet-Based Microfluidic Platforms for the Encapsulation and Screening of Mammalian Cells and Multicellular Organisms

22

Droplet-Based Microfluidic Platforms for the Encapsulation and Screening of Mammalian Cells and Multicellular Organisms Original Research Article

23

Droplet-based microfluidic sensing system for rapid fish freshness determination

24

Droplet-based microfluidics for dose–response assay of enzyme inhibitors by electrochemical method Original Research Article

25

Droplet-based microscale colorimetric biosensor for multiplexed DNA analysis via a graphene nanoprobe Original Research Article

26

Droplet-based synthetic method using microflow focusing and droplet fusion

27

Dropletde-entrainmentbyinertialimpactiononverticalrodsinanair-dropletmixtureflowOriginalResearchArticle

28

Dropletentrainmentcorrelationinverticalupwardco-currentannulartwo-phaseflowOriginalResearchArticle

29

Droplet-free TiC nanocrystal-containing diamond-like carbon coatings deposited by combined cathodic arc MF magnetron sputtering

30

Droplet-induced anomalous deformation of a thin micro-plate

31

Droplets formation in turbulent mixing of two immiscible fluids in a new type of static mixer

32

Droplets from the metal surfaces irradiated by a high-intensity pulsed ion beam

33

Droplets profiles and wetting transitions in electric fields

34

Droplets Tracing in a T-junction Microchannel

35

DropletsdepositioninsteampipingconnectingsteamgeneratorandsteamturbineinnuclearplantOriginalResearchArticle

36

Droplet-size dependence of the electron transfer rate across the single-microdroplet/water interface

37

Drop-off during ribosome hopping

38

Drop-on-demand deposition of superheated metal droplets for selective infiltration manufacturing

39

Drop-on-demand deposition of superheated metal droplets for selective infiltration manufacturing

40

Drop-on-demand drop formation of colloidal suspensions

41

Drop-on-demand printing of cells and materials for designer tissue constructs

42

Dropout Analysis of a National Social Health Insurance Program at Pokhara Metropolitan City, Kaski, Nepal

43

Dropout and early unemployment

44

Dropout from outpatient mental health care: results from the Israel National Health Survey

45

Drop-out from primary schools in tribal India: A case study of the Ho in Parampancho, West Singhbhum

46

Dropout from Rehabilitation and Its Associated Factors in Children with Developmental Disabilities in Tehran Rehabilitation Centers

47

Dropout Prediction and Reduction in Distance Education Courses with the Learning Analytics Multitrail Approach

48

Dropout rate and associated factors in patients with bipolar disorders

49

Dropout rate for intent-to-treat and per protocol analye

50

DROPOUT STEREOTYPE AND TRANSFORMATION OF ORANG KUALA S ORANG ASLI: A REVIEW ON THE ADAPTATION OF THE NEW HUMAN CAPITAL

51

Dropouts and Social Determinants of Health; Policy for the Prevention of School Dropout, Qualitative Study of the Causes and Interventions

52

Drop-outs in tamoxifen prevention trials

53

Drop-outs in tamoxifen prevention trials

54

Dropouts Problem among Karnataka (India) Tribal Children: Where Rubber hits the Road?

55

Dropouts versus completers among chronically depressed outpatients

56

Dropped Gallstones Causing Transdiaphragmatic Migration and Thoracic Empyema

57

Dropped head syndrome after radiotherapy for lymphoma: A report of three cases

58

Dropped Head Syndrome in a Patient with Aeromonas hydrophila-induced Septic Arthritis of the Shoulder

59

Dropped-head and bent-spine syndromes; axial myopathies?

60

Dropping out of mental health treatment among patients with depression and anxiety by type of provider: results of the European Study of the Epidemiology of Mental Disorders

61

Dropping out of school: A review of intervention programs

62

Dropping rates of elaiosome-bearing seeds during transport by ants (Formica polyctena Foerst.): Implications for distance dispersal

63

Dropping the weight stigma: Nostalgia improves attitudes toward persons who are overweight

64

Dropping variables versus use of proxy variables in linear regression

65

Drops deformation and magnetic permeability of a ferrofluid emulsion

66

Drops that pull themselves up

67

Drop-Size Analysis in a Two-Phase Reactive Liquid-Liquid System on a Bubble-Cap Tray

68

Dropstones, pseudoplanktonic forms and deep-water decapod crustaceans within a Lutetian condensed succession of central Istria (Croatia): relation to palaeoenvironmental evolution and palaeogeography

69

Dropstones: their origin and significance

70

Dropstones: their origin and significance: a comment

71

Drop-to-drop microextraction across a supported liquid membrane by an electrical field under stagnant conditions

72

Drop-weight test based identification of elastic half-space model parameters

73

Dropwise condensation from flowing air–steam mixtures: Diffusion resistance assessed by controlled drainage

74

Dropwise condensation heat transfer on ion implanted aluminum surfaces

75

DROPWISE CONDENSATION OF STEAM ON A SMALL TUBE BUNDLE AT TURBINE CONDENSER CONDITIONS

76

DROPWISE CONDENSATION OF STEAM ON A SMALL TUBE BUNDLE AT TURBINE CONDENSER CONDITIONS AN EXPERIMENTAL STUDY OF THE TWO-PHASE FLOW ADJACENT TO A WIRE IN NUCLEATE BOILING UNDER AN ELECTRIC FIELD

77

Dropwise condensation of steam on ion implanted titanium surfaces

78

Dropwise condensation on L-B film surface

79

Dropwise condensation rate of water breath figures on polymer surfaces having similar surface free energies

80

Dropwise cooling: Experimental tests by infrared thermography and numerical simulations

81

Dropwise deposition and wetting of nanoparticle suspensions

82

Drosophila Atrophin Homolog Functions as a Transcriptional Corepressor in Multiple Developmental Processes

83

Drosophila Auditory Organ Genes and Genetic Hearing Defects

84

Drosophila BAP60 is an Essential Component of the Brahma Complex, Required for Gene Activation and Repression

85

Drosophila BTB/POZ Domains of “ttk Group” Can Form Multimers and Selectively Interact with Each Other

86

Drosophila Calmodulin Mutants With Specific Defects in the Musculature or in the Nervous System

87

Drosophila Checkpoint Kinase 2 Couples Centrosome Function and Spindle Assembly to Genomic Integrity

88

Drosophila Clock Can Generate Ectopic Circadian Clocks

89

Drosophila cohesins DSA1 and Drad21 persist and colocalize along the centromeric heterochromatin during mitosis

90

Drosophila cryb mutation reveals two circadian clocks that drive locomotor rhythm and have different responsiveness to light

91

Drosophila CTCF Is Required for Fab-8 Enhancer Blocking Activity in S2 Cells

92

Drosophila Cytokine Unpaired 2 Regulates Physiological Homeostasis by Remotely Controlling Insulin Secretion

93

Drosophila DPM Neurons Form a Delayed and Branch-Specific Memory Trace after Olfactory Classical Conditioning

94

Drosophila Dscam Is an Axon Guidance Receptor Exhibiting Extraordinary Molecular Diversity

95

Drosophila Dumbfounded: A Myoblast Attractant Essential for Fusion

96

Drosophila Enhancer of Zeste/ESC Complexes Have a Histone H3 Methyltransferase Activity that Marks Chromosomal Polycomb Sites

97

Drosophila fasciclinII Is Required for the Formation of Odor Memories and for Normal Sensitivity to Alcohol

98

Drosophila female precopulatory behavior is modulated by ecdysteroids

99

Drosophila Fragile X-Related Gene Regulates the MAP1B Homolog Futsch to Control Synaptic Structure and Function

100

Drosophila Gain-of-Function Mutant RTK Torso Triggers Ectopic Dpp and STAT Signaling

101

Drosophila genome sequence, a model for the human

102

Drosophila Genome-wide Obesity Screen Reveals Hedgehog as a Determinant of Brown versus White Adipose Cell Fate

103

Drosophila gustatory receptors: from gene identification to functional expression

104

Drosophila immunity: paths and patterns

105

Drosophila immunity: two paths to NF-κB

106

Drosophila male courtship behavior is modulated by ecdysteroids

107

Drosophila males transfer antibacterial proteins from their accessory gland and ejaculatory duct to their mates

108

Drosophila melanogaster and D. simulans rescue strains produce fit offspring, despite divergent centromerespecific histone alleles

109

Drosophila melanogaster as a Model to Study Human Neurodegenerative Diseases

110

Drosophila melanogaster Laboratory Rearing for Wolbachia-Based Control Programs, a Component of Dengue Control

111

Drosophila melanogaster males increase the number of sperm in their ejaculate when perceiving rival males

112

Drosophila melanogaster Methoprene-tolerant (Met) gene homologs from three mosquito species: Members of PAS transcriptional factor family

113

Drosophila melanogaster syncytial nuclear divisions are patterned: time-lapse images, hypothesis and computational evidence

114

Drosophila microRNAs Are Sorted into Functionally Distinct Argonaute Complexes after Production by Dicer-1

115

Drosophila model increases understanding of fragile-X syndrome

116

Drosophila Myc Regulates Organ Size by Inducing Cell Competition

117

Drosophila neural progenitor polarity and asymmetric division

118

Drosophila Neuroblasts Sequentially Express Transcription Factors which Specify the Temporal Identity of Their Neuronal Progeny

119

Drosophila p53 Binds a Damage Response Element at the reaper Locus

120

Drosophila p53 Is a Structural and Functional Homolog of the Tumor Suppressor p53

121

Drosophila PAR-1 and 14-3-3 Inhibit Bazooka/PAR-3 to Establish Complementary Cortical Domains in Polarized Cells

122

Drosophila Proteasome Regulator REGγ: Transcriptional Activation by DNA Replication-related Factor DREF and Evidence for a Role in Cell Cycle Progression

123

Drosophila Replication and Repair Proteins: Proliferating Cell Nuclear Antigen (PCNA)

124

Drosophila Rho-Associated Kinase (Drok) Links Frizzled-Mediated Planar Cell Polarity Signaling to the Actin Cytoskeleton

125

Drosophila Rhomboid-1 Defines a Family of Putative Intramembrane Serine Proteases

126

Drosophila serpin 27A is a likely target for immune suppression of the blood cell-mediated melanotic encapsulation response

127

Drosophila Sir2 Is Required for Heterochromatic Silencing and by Euchromatic Hairy/E(Spl) bHLH Repressors in Segmentation and Sex Determination

128

Drosophila song as a species-specific mating signal and the behavioural importance of Kyriacou & Hall cycles in D. melanogaster song

129

Drosophila still flying high in cancer research

130

Drosophila Tsc1 Functions with Tsc2 to Antagonize Insulin Signaling in Regulating Cell Growth, Cell Proliferation, and Organ Size

131

Drosophila Tufted Is a Gain-of-Function Allele of the Proneural Gene amos

132

Drosophila wingless and Pair-Rule Transcripts Localize Apically by Dynein-Mediated Transport of RNA Particles

133

Drosophila Zinc Finger Protein CG9890 Is Colocalized with Chromatin Modifying and Remodeling Complexes on Gene Promoters and Involved in Transcription Regulation

134

Dross formation during remelting of aluminum 5182 remelt secondary ingot (RSI)

135

Dross formation during remelting of aluminum 5182 remelt secondary ingot (RSI)

136

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial

137

Drought 2002 in Colorado: An Unprecedented Drought or a Routine Drought?

138

Drought acclimation and lipid composition in Folsomia candida: implications for cold shock, heat shock and acute desiccation stress

139

Drought acclimation confers cold tolerance in the soil collembolan Folsomia candida

140

Drought adaptations in wild barley (Hordeum spontaneum) grown in Iran

141

Drought affects the fluxes of carbon to roots and soil in 13C pulse-labelled plants of wheat

142

Drought affects the fluxes of carbon to roots and soil in 13C pulse-labelled plants of wheat

143

Drought Allocations Using the Systems Impact Assessment Model: Klamath River

144

Drought alters respired δ13CO2 from autotrophic, but not heterotrophic soil respiration

145

Drought alters respired δ13CO2 from autotrophic, but not heterotrophic soil respiration

146

Drought analysis in the Lakes of Iran (Case study: Lake Urmia and Gavkhuni Swamp)

147

Drought and Aquatic Ecosystems: Effects and Responses, P. Sam Lake. Wiley-Blackwell, Oxford, Chichester, Hoboken (2011). xiv+381 pp., Price £55.00, Paperback, ISBN: 978-1-4051-8560-8 (also four electronic formats)

148

Drought and climatic change impact on streamflow in small watersheds Original Research Article

149

Drought and clipping effects on tiller demography andgrowth of two tussock grasses in Utah

150

Drought and declining reservoirs: Comparing media discourse in Arizona and New Mexico, 2002–2004

151

Drought and disputes, deluge and dearth: climatic variability and human response in colonial Oaxaca, Mexico

152

Drought and ecosystem carbon cycling

153

Drought and flood signals in subtropical estuaries recorded by stable isotope ratios in bivalve shells

154

Drought and grazing patch dynamics under different grazing management

155

Drought and malaria retreat in the Sahel, West Africa

156

Drought and Salinity Impacts on Bread Wheat in a Hydroponic Culture: A Physiological Comparison

157

Drought and salt tolerance enhancement of transgenic Arabidopsis by overexpression of the vacuolar pyrophosphatase 1 (EVP1) gene from Eucalyptus globulus

158

Drought and saving in West Africa: are livestock a buffer stock?

159

Drought and spring cooling induced recent decrease in vegetation growth in Inner Asia

160

Drought and the Impact of Natural Saline River on the Quality of Surface Water Resources In Karoon River(IRAN)

161

Drought changes the dynamics of trace element accumulation in a Mediterranean Quercus ilex forest

162

Drought class transition analysis through Markov and Loglinear models, an approach to early warning

163

Drought constraints on transpiration and canopy conductance in mature aspen and jack pine stands

164

Drought decreases soil enzyme activity in a Mediterranean Quercus ilex L. forest

165

Drought decreases soil enzyme activity in a Mediterranean Quercus ilex L. forest

166

Drought disturbance from climate change: response of United States forests

167

Drought duration and frequency in the U.S. Corn Belt during the last millennium (AD 992–2004)

168

Drought early warning system in reservoir operation: Theory and practice

169

Drought effects on elongation kinetics and sugar deposition in the elongation zone of durum wheat (Triticum durum Desf.) leaves

170

Drought effects on the early development stages of Panicum virgatum L.: Cultivar differences

171

Drought effects on water relations in beech: The contribution of exchangeable water reservoirs

172

DROUGHT EFFECTS ON YIELD TRAITS OF SOME SUNFLOWER INBRED LINES

173

Drought evolution at various time scales in the lowland regions and their impact on vegetable crops in the Czech Republic

174

Drought experiments within the Solling roof project

175

Drought Flow from Hillslope

176

Drought Flow from Hillslope

177

Drought forecasting based on the remote sensing data using ARIMA models

178

Drought forecasting using feed-forward recursive neural network

179

Drought forecasting using feed-forward recursive neural network

180

Drought forecasting using the Standardized Precipitation Index

181

Drought frequency analysis using cluster analysis and bivariate probability distribution

182

Drought identification and characterization in Jordan

183

Drought impacts on the water quality of freshwater systems; review and integration

184

Drought in groundwater—drought distribution and performance indicators

185

Drought induced pulses of image from a Canadian shield wetland: use of δ34S and δ18O in image to determine sources of sulfur

186

Drought is a major yield loss factor for rainfed East African highland banana

187

Drought mitigation using operative indicators in complex water systems

188

Drought modeling – A review

189

Drought Monitoring and Corn Yield Estimation in Southern Africa from AVHRR Data

190

Drought Monitoring and Prediction using K-Nearest Neighbor Algorithm

191

Drought Monitoring Based on the SPI and RDI Indices under Climate Change Scenarios (Case Study: Semi-Arid Areas of West Golestan Province)

192

Drought monitoring in Iran using the perpendicular drought indices

193

Drought Monitoring in Southern Coasts of Iran

194

Drought monitoring using a Soil Wetness Deficit Index (SWDI) derived from MODIS satellite data

195

Drought Monitoring Using Climatic Indices and Geostatistic Technique (Case Study: Hossein Abad Plain, Sarbisheh, Iran)

196

Drought Monitoring Using MODIS Land Surface Temperature and Normalized Difference Vegetation Index Products in Semi-Arid Areas of Iran

197

Drought Monitoring Using Vegetation Indices and MODIS Data (Case Study: Isfahan Province, Iran)

198

Drought Occurrence Pattern in Tigray Region, Northern Ethiopia

199

Drought Occurrence Probabilities and Risks of Dependent Hydrologic Processes

200

Drought planning and water allocation: an assessment of local capacity in Minnesota

201

Drought prediction using the Along Track Scanning Radiometer (ATSR2) on board ERS2 satellite Original Research Article

202

Drought probabilities and return period for annual streamflows series

203

Drought resistance of 2-year-old saplings of Mediterranean forest trees in the field: relations between water relations, hydraulics and productivity

204

Drought response of two bedding plants

205

Drought responses of Arrhenatherum elatius grown in plant assemblages of varying species richness

206

Drought Risk Assessment In Iraq Using Remote Sensing And GIS Techniques

207

Drought Risk Assessment in Western Inner-Mongolia

208

Drought Risk Assessment: A Case Study in Punjab, Pakistan

209

Drought risk management in agricultural sector with an emphasis on the socioeconomic dimension under Fuzzy Logic in the Sistan region

210

Drought Risk Vulnerability Parameters among Wheat

211

Drought Scenario Analysis Using RiverWare: A Case Study in Urumqi River Basin, China

212

Drought signals in tree-ring stable oxygen isotope series of Qilian juniper from the arid northeastern Tibetan Plateau

213

Drought stress and fluctuating asymmetry in Quercus undulata leaves: confounding effects of absolute and relative amounts of stress?

214

Drought Stress Effect on germination and Seedling Growth Indices in 5 Sugar Beet Genotypes

215

Drought stress effect on some phonological traits of advanced lines of bread wheat

216

Drought stress has contrasting effects on antioxidant enzymes activity and phenylpropanoid biosynthesis in Fraxinus ornus leaves: An excess light stress affair?

217

Drought Stress Impact on Some Biochemical and Physiological Traits of 4 Groundcovers (Lolium perenne, Potentilla spp, Trifolium repens and Frankinia spp) with Potential Landscape Usage

218

Drought Stress in Iranian Endemic Savory (Satureja rechingeri): In vivo and In vitro Studies

219

DROUGHT STRESS INCREASES THE EXPRESSION OF WHEAT LEAF RIBULOSE- 1, 5- BISPHOSPHATE CARBOXYLASE/OXYENASE PROTEIN

220

Drought stress tolerance based on selection indices of resistant crops variety

221

Drought stress tolerance of barley (Hordeum vulgare L.) affected by priming with PEG

222

Drought stress, plant water status, and floral trait expression in fireweed, Epilobium angustifolium (Onagraceae)

223

Drought Stress: A Review

224

Drought Stress-Induced Changes at Physiological and Biochemical Levels in Some Common Vetch (Vicia sativa L.) Genotypes

225

Drought stress-induced compositional changes in tolerant transgenic rice and its wild type

226

Drought stress-induced upregulation of components involved in ferredoxin-dependent cyclic electron transfer

227

Drought threatened semi-arid ecosystems in the Inner Asia

228

Drought tolerance associated with vertical stratification of two co-occurring epiphytic bromeliads in a tropical dry forest

229

Drought Tolerance in Cultivated and Wild Barley Genotypes: The Role of Root System Characteristics

230

Drought Tolerance is Associated with Rooting Depth and Stomatal Control of Water Use in Clones of Coffea canephora

231

Drought Tolerance of Selected Eragrostis Species Correlates with Leaf Tensile Properties

232

Drought Tolerance Screening in Thirty Common Wheat (Triticum aestivum L.) Genotypes

233

Drought tolerance through overexpression of monoubiquitin in transgenic tobacco

234

Drought tolerance through over-expression of the expansin gene TaEXPB23 in transgenic tobacco

235

Drought tolerance, phosphorus efficiency and yield characters of upland rice lines

236

DROUGHT TOLERANT WHEAT CULTIVAR (RAJ) FOR RAINFED AREAS OF KPK, PAKISTAN

237

Drought Utilization Management of Surface and Ground Water (Case study: Qaryat-Al-Arab Watershed)

238

Drought variability and its climatic implications

239

Drought variation trends in different subregions of the Chinese Loess Plateau over the past four decades

240

Drought vulnerability assessment: The case of wheat farmers in Western Iran

241

Drought vulnerability drives land-use and land cover changes in the Rift Valley dry lands of Ethiopia

242

Drought year changes in streambank profiles on incised streams in the Sierra Nevada Mountains

243

Drought, Abscisic Acid and Transpiration Rate Effects on the Regulation of PIP Aquaporin Gene Expression and Abundance in Phaseolus vulgaris Plants

244

Drought, but not salinity, determines the apparent effectiveness of halophytes colonized by arbuscular mycorrhizal fungi

245

Drought, floods and water quality: Drivers of a severe hypoxic blackwater event in a major river system (the southern Murray–Darling Basin, Australia)

246

Drought-adaptive mechanisms involved in the escape/tolerance strategies of Arabidopsis Landsberg erecta and Columbia ecotypes and their F1 reciprocal progeny

247

Drought-induced changes and recovery of photosynthesis in two bean cultivars (Phaseolus vulgaris L.)

248

Drought-induced changes in acid phosphatase activities in wheat in relationship with phosphorus

249

Drought-induced chilling tolerance in cucumber involves Drought-induced chilling tolerance in cucumber involves

250

Drought-induced reduction in uptake of recently photosynthesized carbon by springtails and mites in alpine grassland

251

Drought-induced reduction in uptake of recently photosynthesized carbon by springtails and mites in alpine grassland

252

Drought-induced responses of photosynthesis and antioxidant metabolism in higher plants Review Article

253

Drought-induced variations of water relations parameters in Olea europaea

254

Drought-induced weakening of growth–temperature associations in high-elevation Iberian pines

255

Drought-resistant physiological characteristics of four shrub species in arid valley of Minjiang River, China

256

Drought-responsive mechanisms in rice genotypes with contrasting drought tolerance during reproductive stage

257

Droughts and famines: The underlying factors and the causal links among agro-pastoral households in semi-arid Makueni district, Kenya

258

DROUGHTS AND THEIR IMPACT ON THE ALBANIAN TERRITORY

259

Droughts as random events in the Maya lowlands

260

Drought-sensitivity ranking of deciduous tree species based on thermal imaging of forest canopies

261

Drove roads: Keystone structures that promote ant diversity in Mediterranean forest landscapes

262

Drowned coralline algal dominated deposits off Lanai, Hawaii; carbonate accretion and vertical tectonics over the last 30 ka

263

Drowned shelf-edge deltas, barrier islands and related features along the outer continental shelf north of the head of De Soto Canyon, NE Gulf of Mexico

264

Drowning by numbers and itʹs

265

Drowning discontinuities and stratigraphic correlation in platform carbonates. The late Barremian–early Aptian record of southeast France

266

Drowning in information, but thirsty for knowledge

267

Drowning of a nearshore peat-forming environment, Atane Formation (Cretaceous) at Asuk, West Greenland: sedimentology, organic petrography and geochemistry

268

Drowning out the protection racket: partner manipulation or drought can strengthen ant–plant mutualism

269

Drowning out the protection racket: partner manipulation or drought can strengthen ant–plant mutualism

270

Drowning-out crystallisation of sodium sulphate using aqueous two-phase systems

271

Drowning-out crystallization of l-proline: Effect of anti-solvent composition and processing parameters on crystal size and shape

272

Drowsiness Analysis Using Common Spatial Pattern and Extreme Learning Machine Based on Electroencephalogram Signal

273

Drowsiness Detection – A Visual System for Driver Support

274

Drs. Landon and Kahn respond:

275

dRTP and dPTP a complementary nucleotide couple for the Sequence Saturation Mutagenesis (SeSaM) method

276

Drucker–Prager–Cap creep modelling of pebble beds in fusion blankets

277

Drudeʹs model calculation rule on electrical transport in Sb-doped SnO2 thin films, deposited via sol–gel Original Research Article

278

Druen complement component C3a and C5a promote choroidal neovacularization

279

Drug Use Evaluation of Three Widely Prescribed Antibiotics in a

280

Drug absorption and release properties of crosslinked hydrogels based on diepoxy-terminated poly(ethylene glycol)s and aliphatic polyamines — a study on the effect of the gel molecular structure

281

Drug abuse among nurses: A neglected challenge

282

Drug Abuse among University Students of Rafsanjan, Iran

283

Drug abuse and aggression between intimate partners: A meta-analytic review

284

Drug abuse and bipolar disorder: comorbidity or misdiagnosis?

285

Drug abuse in older US adults worries experts

286

Drug Abuse in Prishtina Region

287

Drug Abuse Pattern and High Risk Behaviors among Addicts in Shahroud County of Semnan Province, Northeast Iran in 2009

288

Drug Abuse Research Trend Investigation with Text Mining

289

Drug abuse toll uncovered in Kenya

290

Drug abuse, HIV/AIDS and stigmatisation in a Dai community in Yunnan, China

291

Drug abuse: A significant variable in schizophrenia research

292

Drug Action at the 5-HT(1A) Receptor in Vivo: Autoreceptor and Postsynaptic Receptor Occupancy Examined with PET and [carbon:yl-11C]WAY-100635

293

Drug Action of Ritodrine on the Sarcoplasmic-Reticulum Ca2+-ATPase from Skeletal Muscle

294

Drug actions in preeclampsia: Aspirin, but not magnesium chloride or dihydralazine, differentially inhibits cultured human trophoblast release of thromboxane and prostacyclin without affecting angiotensin II, endothelin-1, or leukotriene B4 secretion

295

DRUG ADDICTION AND HEPATITIS B AND C IN PAKISTAN

296

Drug addiction and HIV infection on rise in Tajikistan

297

Drug addiction and the economic rationalization of gun control

298

Drug addiction and the economic rationalization of gun control

299

Drug Addiction and Vitamin D Supplementation: How to Address a Health Concern in Methadone Treatment?

300

Drug addiction as drive satisfaction ("antidrive") dysfunction

301

Drug Addiction as Risk for Suicide Attempts

302

Drug addiction in Gaza and the illicit trafficking of tramadol

303

Drug addiction: the neurobiology of disrupted self-control

304

Drug administration to poultry

305

Drug adverse events and drop-out risk: A clinical case

306

Drug advertisements and prescribing

307

Drug advertisements and prescribing

308

Drug advertisements in less-developed countries

309

Drug advertisements in medical journals

310

Drug advertisements that go straight to the hippocampus

311

Drug advertising in medical journals

312

Drug advertising in medical journals

313

Drug advertising in medical journals

314

Drug advertising in medical journals

315

Drug advertising in medical journals

316

Drug advertising in medical journals

317

Drug affinity to immobilized target bio-polymers by high-performance liquid chromatography and capillary electrophoresis

318

Drug allergic reactions and distress vulnerability

319

Drug allergies among patients with borderline personality symptomatology

320

321

Drug allergy transmitted by passionate kissing

322

Drug and alcohol abuse: A clinical guide to diagnosis and treatment (4th ed.) : Marc A. Schuckit. New York: Plenum Press, 1995. 371 pp. (xviii), $34.50

323

Drug and Alcohol Education for Consumer Workers and Caregivers: A Pilot Project Assessing Attitudes Toward Persons With Mental Illness and Problematic Substance Use

324

Drug and alcohol use among drivers admitted to a Level-1 trauma center

325

Drug and Alcohol Use in Emergency Medicine Residency: An Impaired Residentʹs Perspective

326

Drug and alcohol use in Spain: consumption habits, attitudes and opinions

327

Drug and cell encapsulation: Alternative delivery options for the treatment of malignant brain tumors

328

Drug and chemical metabolites in clinical toxicology investigations: The importance of ethylene glycol, methanol and cannabinoid metabolite analyses

329

Drug and DNA delivery to mitochondria

330

Drug and DNA delivery to mitochondria

331

Drug and ECT treatment of depression in the elderly, 1996–2001: a literature review

332

Drug and gene delivery to mucosal tissues: the mucus barrier

333

Drug and herbal medicine-induced nephrotoxicity in children; review of the mechanisms

334

Drug Attitude Inventory in Patients with Bipolar Disorder: Psychometric Properties

335

Drug biotransformation by human hepatocytes. In vitro/in vivo metabolism by cells from the same donor

336

DRUG BIT CUTTING TRACE IMAGE COLOURS AND CUTTING FORCE FLUCTUATION RELATION

337

Drug bulletins: independent information for global use

338

Drug Calculation Cards and Medication Errors in the Neonatal Intensive Care Units

339

Drug calculation skills — Are we running scared?

340

Drug Calculations for Nurses: Robert Lapham, Heather Agar, Arnold, 1995, 0-340604-79-4, 250 pages, Price £5.99

341

Drug choices in the treatment of atrial fibrillation

342

Drug classification systems: Applications and characteristics

343

Drug Clearance and Arterial Uptake After Local Perivascular Delivery to the Rat Carotid Artery

344

Drug combinations best in acute asthma attacks

345

Drug combinations for HD tested in Drosophila

346

Drug combinations for malaria: time to ACT?

347

Drug combinations in pain treatment: a review of the published evidence and a method for finding the optimal combination

348

Drug companies can broadcast across Europe

349

Drug companies caught again for fixing worldwide vitamin prices

350

Drug company sued over research trial in Nigeria

351

Drug company trials come under increasing scrutiny

352

Drug comparison and categorizing regarded with human serum albumin

353

Drug complications poorly recorded in medical charts

354

Drug courts for DWI offenders? The effectiveness of two hybrid drug courts on DWI offenders

355

Drug courts: A bridge between criminal justice and health services

356

Drug Craving Terminology among Opiate Dependents;

357

Drug Cravings and Its Relationship With Family Communication Patterns and Resiliency Through the Mediatory Role of Difficulty in Cognitive Emotion Regulation

358

Drug crops threaten Colombian birds

359

360

Drug delivery and tissue engineering applications of biocompatible pectin–chitin/nano CaCO3 composite scaffolds

361

Drug delivery applications of supercritical fluid technology

362

Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: Illustration with the case of taxane therapeutics

363

Drug delivery devices based on macroporous silica spheres

364

Drug Delivery for Brains and Central Nervous System

365

Drug delivery for in vitro fertilization: Rationale, current strategies and challenges

366

Drug delivery from gold and titanium surfaces using self-assembled monolayers

367

Drug delivery from hydrophobic-modified mesoporous silicas: Control via modification level and site-selective modification

368

Drug delivery in degenerative joint disease

369

Drug delivery in degenerative joint disease: Where we are and where to go?

370

Drug delivery investigations of quaternised poly(propylene imine) dendrimer using nimesulide as a model drug

371

Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors

372

Drug Delivery Platforms for Vaginal Infection: Biological Barriers, Microbe-Associated Infections, and Delivery

373

Drug delivery property, bactericidal property and cytocompatibility of magnetic mesoporous bioactive glass

374

Drug delivery strategies for photodynamic antimicrobial chemotherapy: From benchtop to clinical practice

375

Drug delivery strategies in the therapy of inflammatory bowel disease

376

Drug delivery strategies to treat age-related macular degeneration

377

Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities

378

Drug delivery system based on cyclodextrin-naproxen inclusion complex incorporated in electrospun polycaprolactone nanofibers

379

Drug delivery systems : Vascant V. Ranade and Mannfred A. Hollinger CRC Press, Boca Raton, Florida, 1995, 364 pp. Dr Lisa Brannon-Peppas

380

Drug delivery systems using sandwich configurations of electrospun poly(lactic acid) nanofiber membranes and ibuprofen

381

Drug delivery systems: polymers and drugs monitored by capillary electromigration methods

382

Drug delivery therapies I: General trends and its importance on bone tissue engineering applications

383

Drug delivery therapies II.: Strategies for delivering bone regenerating factors

384

Drug Delivery through Nose: A Noninvasive Technique for Brain Targeting

385

Drug delivery to mitochondria: the key to mitochondrial medicine

386

Drug delivery to mitochondria: the key to mitochondrial medicine

387

Drug delivery to peroxisomes: Employing unique trafficking mechanisms to target protein therapeutics

388

Drug delivery to solid tumors by elastin-like polypeptides

389

Drug delivery to the brain in Alzheimerʹs disease: Consideration of the blood–brain barrier

390

Drug delivery to the brain-just a sniff away

391

Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?

392

Drug delivery to the posterior segments of the eye

393

Drug delivery vehicles on a nano-engineering perspective

394

Drug Demand Function for Iranian Urban Households Based on Householdsʹ Budget

395

Drug Dependency and Womenʹs Health

396

Drug dependent parents: Childcare responsibilities, involvement with treatment services, and treatment outcomes

397

Drug deregulation in Japan likely by 1998

398

Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase

399

Drug design and synthesis of ε opioid receptor agonist: 17-(cyclopropylmethyl)-4,5α-epoxy-3,6β-dihydroxy-6,14-endoethenomorphinan-7α-(N-methyl-N-phenethyl)carboxamide (TAN-821) inducing antinociception mediated by putative ε opioid receptor Original Resea

400

Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV protease Original Research Article

401

Drug design, synthesis, and evaluation of a non-sugar-based selectin antagonist

402

Drug design; HIV; Organosilane; Protease inhibitor; Silanediol

403

Drug detection based on the conformational changes of calmodulin and the fluorescence of its enhanced green fluorescent protein fusion partner Original Research Article

404

Drug detection by tandem mass spectrometry on the basis of adduct formation

405

Drug development and clinical research in the UK

406

Drug development for neglected diseases

407

Drug development for neglected diseases: a deficient market and a public-health policy failure

408

Drug development for tuberculosis: the missing ingredient

409

Drug development output: what proportion for tropical diseases?

410

Drug diffusion from disperse systems with a hydrophobically modified polysaccharide: Enhancer® vs Franz cells

411

Drug diffusion in hydrophobically modified N,N-dimethylacrylamide hydrogels

412

Drug Diffusion Inside a Non-Degradable Hydrogel Microneedle

413

DRUG DISCONTINUATION IN EPILEPTIC CHILDREN: PREDICTIVE VALUE OF THE EEG

414

Drug Discovery Acceleration Using Digital Microfluidic Biochip Architecture and Computer-aided-design Flow

415

Drug discovery and chemokine receptor antagonists: eppur si muove!

416

Drug Discovery and Delivery in the 21st Century

417

Drug Discovery and Evaluation

418

Drug discovery and sea hares: bigger is better

419

Drug Discovery in the Clouds

420

Drug discovery in the new millennium: the pivotal role of biotechnology

421

Drug discovery in the wake of genomics

422

Drug discovery of the future: the implications of the human genome project

423

Drug discovery through stem cell-based organoid models

424

Drug dispensing systems in Gaza hospitals: a comparative study

425

Drug disposition in obesity and protein-energy malnutrition

426

Drug distribution within poly(ɛ-caprolactone) microspheres and in vitro release

427

Drug dosing errors in simulated paediatric emergencies – Comprehensive dosing guides outperform length-based tapes with precalculated drug doses

428

Drug efficacy of praziquantel and albendazole in school children in Mwea Division, Central Province, Kenya

429

Drug efflux transporters in the CNS

430

Drug elimination in chronic liver diseases

431

Drug eluting stent

432

Drug ELuting Stent Complications

433

Drug eluting stent implantation for the treatment of symptomatic myocardial bridging is associated with favorable peri-procedural results and short-term outcomes

434

Drug Eluting Stent Restenosis

435

Drug eluting stents

436

Drug Eluting Stents Comparisons

437

Drug Eluting Stents I

438

Drug Eluting Stents II

439

Drug Eluting Stents in Diabetic Patients

440

Drug eluting stents may not be the answer for myocardial bridges

441

Drug eluting stents: Comparative results

442

Drug eluting stents: Current status and new developments

443

Drug eluting stents: In stent restenosis

444

Drug eluting stents: Long term results

445

Drug eradicates Chagasʹ parasite in mice

446

Drug evaluations using a novel microphysiometer based on cell-based biosensors

447

Drug excretion in breast milk: mechanisms, models and drug delivery implications for the infant

448

Drug excretion into breast milk—Overview

449

Drug exposed infants in the social welfare system and Juvenile Court

450

Drug firm buys up chain of US cancer clinics

451

Drug firm compensates patients for suspected hepatitis B vaccine failure

452

Drug firm support of American Medical Association ethics effort draws fire

453

Drug firm withdraws statin from the market

454

Drug firms lose patent rights lawsuit against South Africaʹs government

455

Drug firmsʹ representatives express concern over WHOʹs AIDS drug list

456

Drug firms take South Africaʹs government to court

457

Drug firms under fire over anti-competition in USA

458

Drug for impotence breaks prescription records

459

Drug Guru: A computer software program for drug design using medicinal chemistry rules Original Research Article

460

drug hypersensitivity reactions in hospital-admitted children: a single center study in southern iran

461

Drug Hypersensitivity Reactions in Hospital-Admitted Children: A Single Center Study in Southern Iran

462

Drug identification performance on the basis of observable signs and symptoms

463

Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants

464

Drug immunosuppression therapy for adult heart transplantation. Part 2: clinical applications and results

465

Drug impurity profiling: Method optimization on dissimilar chromatographic systems: Part I: pH optimization of the aqueous phase Original Research Article

466

DRUG INDUCED (CALCIUM CHANNEL BLOCKERS) GINGIVAL HYPERPLASIA

467

Drug Induced Autoimmune Hepatitis by Amoxicillin- Clavulanate

468

Drug induced blistering and the plastic surgeon: a case of amitriptyline induced skin necrosis

469

Drug Induced Ectropion: a Systematic Review

470

Drug Induced Gingival Overgrowth and Its Management

471

Drug induced hepatitis among Iranian patients suffering from tuberculosis

472

Drug Induced Sialorrhea and Microfluidic-Chip-Electrophoretic Analysis of Engorged Adult Female Tick Saliva of Haemaphysalis longicornis (Acari: Ixodidae)

473

Drug Induced Sleep Endoscopy in Obstructive Sleep Apnea

474

Drug industry lobbies against European research-data directive

475

Drug Information Resources at Private Community Pharmacies in Kuwait

476

Drug Injecting and HIV Infection: Global Dimensions and Local Responses; Edited by Gerry Stimson, Don C. Des Jarlais and Andrew Ball. UCL Press Ltd, London, 1998. 294 pp, £14.95 (paper).

477

Drug injection and associated factors among the elderly living with HIV/AIDS in Tehran, Iran

478

Drug injection cessation among HIV-infected injecting drug users

479

Drug interaction between rifampicin and sirolimus in transplant patients

480

Drug Interaction of Glycyrrhiza glabra L. with Chemical Drugs: A mini Review study

481

Drug interaction of St Johnʹs wort with ciclosporin

482

Drug Interactions Among Hospitalized Patients in Intensive Care Units and Infectious Ward, Hamadan, Iran

483

Drug interactions and anti-infective therapies

484

Drug Interactions between Psychoactive Agents and Antiepileptic Agents

485

Drug Interactions Casebook: The Cytochrome P450 System and Beyond, 2nd ed.: By Neil B. Sandson. Washington, DC, American Psychiatric Press, 2003 ($35.50, paperback ed.), 334 pp

486

Drug interactions in cancer patients: A hidden risk?

487

Drug Interactions in Iranian Veterans With Chronic Spinal Cord Injury - A Descriptive Study

488

Drug Interactions of Green Tea

489

Drug Interactions of Medicinal Plants with Chemical Antidiabetic Drugs

490

Drug Interactions of Metformin Involving Drug Transporter Proteins

491

Drug Interactions of Psychiatric and COVID-19 Medications

492

Drug interactions of zonisamide with phenytoin and sodium valproate: serum concentrations and protein binding

493

Drug interactions with potential rubber closure extractables: Identification of thiol–disulfide exchange reaction products of captopril and thiurams

494

Drug interactions with the taxanes: clinical implications

495

Drug interactions with zileuton

496

Drug interactions with zileuton

497

Drug interactions—fact or fiction?

498

Drug intervention trials in sepsis

499

Drug intervention trials in sepsis: divergent results

500

Drug kinetics and drug resistance in optimal chemotherapy

501

Drug Literacy in Iran: the Experience of Using “The Single Item Health Literacy Screening (SILS) Tool”

502

Drug loaded poly[Lac(Glc-Leu)] microparticles: Formulation and release characteristics

503

Drug loaded thermoresponsive and cytocompatible chitosan based hydrogel as a potential wound dressing

504

Drug loading onto ion-exchange microspheres: Modeling study and experimental verification

505

Drug loading, dispersion stability, and therapeutic efficacy in targeted drug delivery with carbon nanotubes Original Research Article

506

Drug Management in Crisis and Disaster in Selected Countries and Iran

507

DRUG MANAGEMENT REVIEWS IN DISTRICT DRUG MANAGEMENT UNIT AND GENERAL HOSPITAL

508

Drug may avoid need for parathyroidectomy

509

Drug Mediated S-glutathionylation of PDI leads to alterations in secondary structure, inhibition of isomerase activity, and triggers ER-stress induced apoptosis

510

Drug metabolism and drug interactions in the elderly

511

Drug metabolism enzymes in a steatotic model of rat treated with a high fat diet and a low dose of streptozotocin

512

Drug name confusion: evaluating the effectiveness of capital (“Tall Man”) letters using eye movement data

513

Drug nanocarrier agents based on starch-g-amino acids

514

Drug Nano-Particles Formation by Supercritical Rapid Expansion Method; Operational Condition Effects Investigation

515

Drug partition chromatography on immobilized porcine intestinal brush border membranes

516

Drug Patents 2001: A Review of Pharmaceutical Patenting, 1995–2001

517

Drug permeation modeling through the thermo-sensitive membranes of poly(N-isopropylacrylamide) brushes grafted onto micro-porous films

518

Drug permeation through temperature-sensitive membranes prepared from poly(vinylidene fluoride) with grafted poly(N-isopropylacrylamide) chains

519

Drug policy in China: pharmaceutical distribution in rural areas

520

Drug policy: should the law take a back seat?

521

Drug prescribing practices of general practitioners and paediatricians for childhood diarrhoea in Karachi, Pakistan

522

Drug prescription habits in public and private health facilities in 2 provinces in South Africa

523

Drug Prescription Pattern in a Nigerian Tertiary Hospital

524

Drug prescriptions after acute myocardial infarction: Dosage, compliance, and persistence

525

Drug prescriptions and referral to cardiac rehabilitation after acute coronary events: comparison between men and women in the French PREVENIR Survey

526

Drug prevents SIV infection

527

Drug pricing policies in one of the largest drug manufacturing nations in the world: Are affordability and access a cause for concern?( Editorial Jan-Mar 2015 / Vol 4 / Issue 1)

528

Drug problem recognition among african american drug-using arrestees

529

Drug Properties, Chemical Reactivity and Docking Binding Energy of Cinnamon with Estrogen, Testosterone, Progesterone as Potential Drug: Theoretical Investigation

530

Drug quality, a contributor to drug resistance?

531

Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Cause Interstitial Nephritis: a case Report and Review of Literatures

532

Drug Rash With Eosinophilia and Systemic Symptoms Syndrome in Infancy: A Report of Two Rare Cases

533

Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification

534

Drug Reaction with Eosinophilia and Systemic Symptom in a Patient with Pneumonia and Hyperthyroidism

535

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Presenting with Primary Diagnosis of Hepatocellular Carcinoma

536

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and Myocarditis: A Case Report and Literature Review on Fatal Complications of Reactivated Viral Infections

537

Drug Reaction With Eosinophilia and Systemic Symptoms Induced by Valproic Acid: A Case Report

538

Drug Reaction With Eosinophilia and Systemic Symptoms Induced by Valproic Acid: A Case Report

539

Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin

540

Drug Receptor Identification from Multiple Tissues Using Cellular-Derived mRNA Display Libraries Original Research Article

541

Drug Recognition and Stabilisation of the Parallel-stranded DNA Quadruplex d(TTAGGGT)4 Containing the Human Telomeric Repeat

542

Drug referendum backs Swiss government

543

Drug reimportation: sitting in the middle

544

Drug related deaths in Tehran, Iran: Toxicological, Death and Crime Scene investigations

545

Drug related deaths—causes and numbers

546

Drug Related Hospital Admissions; A Systematic Review of the Recent Literatures

547

Drug release behavior of beads and microgranules of chitosan

548

Drug release behavior of chitosan–montmorillonite nanocomposite hydrogels following electrostimulation

549

Drug Release Characteristics and Tissue Distribution of Rifapentine Polylactic Acid Sustained-Release Microspheres in Rabbits after Paravertebral Implantation

550

Drug release characteristics of phase separation pHEMA sponge materials

551

Drug release from a N-vinylpyrrolidinone/acrylic acid lubricious hydrophilic coating

552

Drug release from a porous ion-exchange membrane in vitro

553

Drug release from a two-layer stent coating considering the viscoelastic property of the arterial wall: A mathematical and numerical study

554

Drug release from calcium and zinc pectinate beads: Impact of dissolution medium composition

555

Drug release from chitosan–alginate complex beads reinforced by a naturally occurring cross-linking agent

556

Drug release from ion-exchange microspheres: Mathematical modeling and experimental verification

557

Drug release from layered double hydroxides and from their polylactic acid (PLA) nanocomposites

558

Drug release from starch-acetate microparticles and films with and without incorporated α-amylase

559

Drug release from α,β-poly(N-2-hydroxyethyl)- -aspartamide-based microparticles

560

Drug release kinetics and biological properties of a novel local drugcarrier system

561

Drug release kinetics from monolayer films of glucose-sensitive microgel

562

Drug release mechanisms of chemically cross-linked albumin microparticles: Effect of the matrix erosion

563

Drug release rate and kinetic investigation of composite polymeric nanofibers

564

Drug Release Studies from Caesalpinia pulcherrima Seed Polysaccharide

565

Drug Release Studies of Naproxen Agglomerates Produced by the Antisolvent Approach in the Presence of Hydroxypropyl Cellulose

566

Drug release through liposome pores

567

Drug Repositioning and Pharmacophore Identification in the Discovery of Hookworm MIF Inhibitors Original Research Article

568

Drug Repositioning: A Review

569

Drug Repurposing for Identification of S1P1 Agonists with Potential Application in Multiple Sclerosis Using In Silico Drug Design Approaches

570

Drug Repurposing Is a New Opportunity for Developing Drugsagainst Neuropsychiatric Disorders

571

Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review

572

Drug resistance among acid-fast bacilli

573

Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city

574

Drug resistance and apoptosis-inducing strategies in cancer therapy

575

Drug resistance and influenza pandemics

576

Drug resistance and influenza pandemics

577

Drug resistance and influenza pandemics

578

Drug resistance and influenza pandemics

579

Drug Resistance and Serotyping of Uropathogenic Escherichia coli Among Patients With Urinary Tract Infection in Rasht, Iran

580

Drug resistance and Susceptibility of Mycobacterium tuberculosis identified at University Kebangsaan Malaysia Medical Centre

581

Drug Resistance and the Prevention Strategies in Food Borne Bacteria: An Update Review

582

Drug resistance and virulence-associated genes screening in Salmonella enterica isolated from Caspian pony, Iran

583

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

584

Drug resistance gene transfer: Stem cell protection and therapeutic efficacy

585

Drug resistance in cancer, J.H. Goldie, A.J. Goldman. Cambridge University Press, Cambridge (1998)

586

Drug resistance in epilepsy: not futile, but complex?

587

Drug Resistance in Equine Parasites: An Emerging Global Problem

588

Drug resistance in isolated bacteria from milk of sbeep and goats witb subclinical mastitis in Sbabrekord district

589

Drug resistance in malaria: Its population biology and implications for control

590

Drug Resistance in the Clinical Management of HIV – A Special Focus on the Adherence Issues

591

Drug resistance in tuberculosis—a reinfection model

592

Drug resistance models for malaria

593

Drug Resistance of Acinetobacter in Selected Hospitals

594

Drug resistance of isolated strains of Pseudomonas Aeruginosa from burn wound infections to selected antibiotics and disinfectants

595

DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS

596

Drug Resistance of Mycobacterium tuberculosis Complex among Newly Diagnosed Tuberculosis Cases in Burkina Faso

597

Drug Resistance of Pseudomonas aeruginosa and Enterobacter cloacae Isolated from ICU, Babol, Northern Iran

598

DRUG RESISTANCE PATTERN AMONG AFB SMEAR POSITIVE RETREATMENT COMPLETED CASES

599

Drug resistance pattern and associated risk factors of tuberculosis patients in the central province of Iran

600

Drug resistance pattern and outcome of treatment in recurrent episodes of tuberculosis

601

Drug Resistance Pattern of Pseudomonas aeruginosa Isolates Carrying MexAB-OprM Efflux Pump’s Associated Genes in Companion Birds with Respiratory Infection

602

Drug resistance pattern of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients at Isfahan AL Zahra hospital, Iran (2009-2010)

603

Drug Resistance Patterns in HIV Patients with Virologic Failure in Iran

604

Drug resistance patterns in pulmonary tuberculosis

605

Drug resistance profile and subtyping of HIV-1 RT gene in Iranian patients under treatment

606

Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells

607

Drug Resistance versus Spiritual Resistance: A Comparative Analysis from the Perspective of Spiritual Health

608

Drug resistance, plasmids, biotypes and susceptibility to bacteriophages of Salmonella isolated from poultry in Canada

609

Drug Resistance: A Periplasmic Ménage à Trois

610

Drug resistance–virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission

611

Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy

612

Drug resistant Plasmodium falciparum in an area of seasonal transmission

613

Drug resistant tuberculosis in Africa: Current status, gaps and opportunities

614

Drug Resistant Tuberculosis: Gold, Glitter and Hope

615

Drug risk assessment with determining the number of sub-populations under finite mixture normal models

616

Drug Safety Crises Management in Pharmacovigilance

617

Drug Screening versus History in detection of substance use in ED Psychiatric Patients

618

619

Drug sensitivity of trypanosome populations from cattle in a peri-urban dairy production system in Uganda

620

Drug sensitivity patterns of bacterial isolates from septic post-operative wounds in a regional referral hospital in Uganda

621

Drug shows potential for treatment of Huntingtonʹs disease

622

Drug shows promise for treatment of Alzheimerʹs disease

623

Drug solubility: how to measure it, how to improve it

624

Drug Stroop performance: Relationships with primary substance of use and treatment outcome in a drug-dependent outpatient sample

625

Drug subsidy could help Tanzania tackle malaria

626

Drug Supply Chain Management and Implementation of Health Reform Plan in Teaching Hospital Pharmacies of Ahvaz, Iran

627

DRUG SUSCEPTIBILITY OF STREPTOCOCCUS PNEUMONIAE STRAINS ISOLATED IN TEHRAN, IRAN

628

Drug Switching, a Creative Approach to Leukemia Therapy

629

Drug target inference through pathway analysis of genomics data

630

Drug targeting of airway surface liquid: A pharmacological MRI approach

631

Drug targeting to choroidal neovascularization

632

Drug targeting to hypoxic tissue using self-inactivating bioreductive delivery systems

633

Drug targeting to the kidney

634

Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells

635

Drug testing litigation: Trends and outcomes

636

Drug testing sworn law enforcement officers: One agencyʹs experience

637

Drug Therapeutic Failures as a Cause of Admission to an Intensive Care Unit at a University Hospital

638

639

640

Drug therapy and microvolt T-wave alternans testing

641

Drug therapy and microvolt T-wave alternans testing

642

Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy

643

Drug therapy for coronary heart disease: the Sheffield table

644

Drug therapy for coronary heart disease: the Sheffield table

645

Drug therapy for coronary heart disease: the Sheffield table

646

Drug therapy for coronary heart disease: the Sheffield table

647

Drug therapy for coronary heart disease: the Sheffield table

648

Drug therapy for coronary heart disease: the Sheffield table

649

Drug Therapy for Hypercholesterolemia in Patients With Cardiovascular Disease: Factors Limiting Achievement of Lipid Goals

650

Drug Therapy for Hypercholesterolemia: Time to End the Double Standard

651

Drug therapy for inflammatory bowel disease in pregnancy and the puerperium

652

Drug therapy for management of obesity

653

Drug therapy for management of obesity

654

Drug Therapy for Small Abdominal Aortic Aneurysm

655

Drug therapy for treatment of obesity

656

Drug therapy for urinary incontinence

657

Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy

658

Drug Therapy in Atrial Fibrillation Management: Where Do We Stand in 2010?

659

Drug therapy in paediatric patients

660

Drug therapy in reproductive endocrinology

661

Drug therapy increases long-term survival in pulmonary hypertension patients

662

Drug therapy of diabetes in the elderly

663

Drug therapy versus implantation of a cardiac defibrillator for the treatment of malignant arrhythmias in left ventricular dysfunction

664

Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism

665

Drug Trafficking and Criminal Justice

666

Drug trajectories among youth undergoing treatment: The influence of psychological problems and delinquency

667

Drug transfer through mucus

668

Drug transfer through mucus

669

Drug transport in corneal epithelium and blood–retina barrier: Emerging role of transporters in ocular pharmacokinetics

670

Drug Transport Mechanism of Oral Antidiabetic Nanomedicines

671

Drug transport mechanisms and release kinetics from molecularly designed poly(acrylic acid-g-ethylene glycol) hydrogels

672

Drug transport proteins in the liver

673

Drug treatment behind bars: Prison-based strategies for change : By Kevin E. Early Praeger Publishers (P.O. Box 5007, Westport, Connecticut 06881-5007), 1996, 192 pp., hardcover—$55.00

674

Drug treatment for bleeding oesophageal varices

675

Drug treatment for Crohnʹs disease

676

Drug treatment of bothersome lower urinary tract symptoms after ureteric JJ-stent insertion: A contemporary, comparative, prospective, randomised placebo-controlled study, single-centre experience

677

Drug treatment of delirium: Past, present and future

678

Drug treatment of non-variceal upper gastrointestinal bleeding

679

Drug treatment of obesity

680

Drug Treatment of Patients with Liver Cirrhosis in a Tertiary Hospital in Northern Ghana: Does It Comply with Recommended Guidelines?

681

Drug treatment outcome methodology (1993–1997): Strengths, weaknesses, and a comparison to the alcohol field

682

Drug treatment-related factors of inadequate seizure control

683

Drug treatments for obesity

684

Drug treatments for obesity

685

Drug treatments for obesity

686

Drug treatments for obesity – Authorsʹ reply

687

Drug treatments for obesity: orlistat, sibutramine, and rimonabant

688

Drug treatments of levodopa-induced dyskinesias

689

Drug Use among Residents of Juvenile Correctional Center in Kerman, Iran, and its Relationship with Personality Dimensions and Self-concept

690

Drug use and abuse in sport

691

Drug use and drinking among students in 36 countries

692

Drug Use and High-Risk Sexual Behaviors of Women at a Drop-In Center in Mazandaran Province, Iran, 2014

693

Drug use and HIV/ AIDS in Burma

694

Drug Use and Sex Work Among At-risk Women: A Qualitative Study of Initial Factors

695

Drug use and the severity of a traffic accident

696

Drug use behaviors among asian drug users in san francisco

697

Drug use behaviour of pregnant women in rural India

698

Drug use during pregnancy

699

Drug use during pregnancy

700

Drug use during pregnancy: are risk classifications more dangerous than the drugs?

701

Drug use evaluation of antibiotics prescribed in a Jordanian Hospital outpatient and emergency clinics using WHO prescribing indicators

702

Drug use evaluation of antibiotics prescribed in a Jordanian hospital outpatient and emergency clinics using WHO prescribing indicators

703

Drug Use Evaluation of Crystalline Penicillin in Pediatrics Ward of Dessie Referral Hospital, North East Ethiopia: A Hospital Based Cross Sectional Study

704

Drug Use Evaluation of Human Intravenous Immunoglobulin (IVIG) in a Teaching Hospital in East of Iran

705

Drug Use for Secondary Prevention of Cardiovascular Diseases in Golestan, Iran: Results From the Golestan Cohort Study

706

Drug use is associated with elevated food consumption in college students

707

Drug Use Pattern Among Elderly People Referred to the Retirement Centers

708

Drug Use Patterns at Major Rock Concert Events

709

Drug usersʹ access to community-based services

710

Drug usersʹ brains to be removed 2 hours after death

711

Drug usersʹ sexual relationships and the social organisation of risk: The sexual relationship as a site of risk management

712

Drug utilisation and self-medication in rural communities in Vietnam

713

Drug utilization and nutrition patterns among children from indigent and emigrant families in Crete, Greece

714

Drug Utilization Evaluation of Agents Administered for Prevention and Treatment of Cancer-Related Infections

715

Drug Utilization Evaluation of Antibiotics in Burn Patients at a Referral Teaching Hospital

716

Drug Utilization Evaluation of Antibiotics in Intensive Care Units of a Referral Teaching Hospital

717

Drug Utilization Evaluation of Carbapenems in a Teaching Hospital in Tabriz-Iran

718

Drug Utilization Evaluation of Carbapenems in a Teaching Hospital in Tabriz-Iran

719

Drug Utilization Evaluation of Cefepime and Meropenem Based on the Infectious Disease Society of America and Defined Daily Dose Guidelines at the Payambare-Azam Bandar Abbas Hospital: A Retrospective Study

720

Drug Utilization Evaluation of Colistin: A Retrospective Study

721

Drug Utilization Evaluation of Imipenem and Intravenous Ciprofloxacin in a Teaching Hospital

722

Drug Utilization Evaluation of Imipenem in an Educational Hospital in Mazandaran Province

723

Drug Utilization Evaluation of Imipenem in Patients Undergoing Bone Marrow Transplantation

724

Drug utilization evaluation of meropenem: an important broad-spectrum antibiotic for the treatment of serious bacterial infections in hospitalized patients

725

Drug utilization evaluation of Rivaroxaban in both inpatient and outpatient settings: Using standard guidelines

726

Drug utilization evaluation of third generation cephalosporins using core drug use indicators

727

Drug Utilization Evaluation of Two Broad-Spectrum Antimicrobials: Cefepime and Piperacillin/Tazobactam in a Teaching Hospital in Tabriz, Iran

728

Drug Utilization Evaluation of Vancomycin in a Referral Infectious Center in Mazandaran Province

729

Drug Utilization Evaluation of Vancomycin in Pediatric Department

730

Drug utilization patterns in Rawalpindi and Islamabad, Pakistan

731

Drug Utilization Review of Conventional Amphotericin B in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplant Center

732

Drug Utilization Review of Vancomycin in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplantation Center

733

Drug Utilization Study on Acute Poisoning Cases Treated at a Tertiary Care Hospital in Western Part of India

734

Drug with potential to clear amyloid

735

Drug/device combinations for local drug therapies and infection prophylaxis

736

Drug-Coated Balloons for Infrapopliteal Disease: Digging Deep to Understand the Impact of a Negative Trial

737

Drug-company sponsorship and the Declaration of Helsinki

738

Drug-company sponsorship and the Declaration of Helsinki

739

Drug-delivering coronary artery stents: bare metal threatened by extinction?

740

Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant Reversal

741

Drug–DNA interaction: A theoretical study on the binding of thionine with DNAs of varying base composition

742

Drug–DNA interactions and their study by UV–Visible, fluorescence spectroscopies and cyclic voltametry

743

Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population

744

Drug-drug co-crystals

745

Drug-Drug Interaction Extraction via Convolutional Neural Networks

746

Drug–drug interaction mediated by inhibition and induction of P-glycoprotein

747

Drug-Drug Interactions among Kidney Transplant Recipients in The Outpatient Setting

748

Drug‐Drug Interactions in Elderly Adults in Dentistry Care: a Cross-Sectional Study

749

Drug-drug interactions in inpatient and outpatient settings in Iran: a systematic review of the literature

750

Drug-Drug Interactions: Influence of verapamil on the pharmacokinetics of sitagliptin in rats and Ex vivo models

751

Drug‑drug Interactions: The Importance of Medication Reconciliation (Letters to the Editor Volume 6 - Issue 1 - January-March 2017 )

752

Drug-drug interation prediction between ketoconazole and anti-liver cancer drug Gomisin G

753

Drug-Drug/Drug-Excipient Compatibility Studies on Curcumin using Non-Thermal Methods

754

Drug-Drug-Induced Akathisia: Two Case Reports

755

Drug-efficacy depends on the inhibitor type and the target position in a metabolic network—A systematic study

756

Drug-eluted stent fracture occurred within 3 years lead to chronic total occlusion and aneurysm

757

Drug-eluting Balloon (DEB) for De-Novo Coronary Artery Disease and In-stent Restenosis: Immediate and Intermediate Term Results from a Prospective Registry

758

Drug-Eluting Balloon for Treatment of Superficial Femoral Artery In-Stent Restenosis

759

Drug-Eluting Balloon Versus Standard Balloon Angioplasty for Infrapopliteal Arterial Revascularization in Critical Limb Ischemia: 12-Month Results From the IN.PACT DEEP Randomized Trial

760

Drug-eluting bioabsorbable stents – An in vitro study

761

Drug-Eluting Compared With Bare-Metal Coronary Stents Among Elderly Patients Original Research Article

762

Drug-eluting stent fracture occurred within 2 days after stent implantation

763

Drug-Eluting Stent Fracture within 6 Days after Stent Implantation

764

Drug-Eluting Stent Fracture: Promise and Performance

765

Drug-Eluting Stent Implantation and Coronary Collateral Growth Attenuation: Is Drug the Only Culprit?

766

Drug-Eluting Stent Implantation May Not Affect Vasomotor Function in Early Phase

767

Drug-Eluting Stent Restenosis: The Pattern Predicts the Outcome Original Research Article

768

Drug-Eluting Stent Thrombosis: A Pooled Analysis

769

Drug-Eluting Stent Thrombosis: A Pooled Analysis: Reply

770

Drug-Eluting Stent Thrombosis: Increasingly Recognized But Too Frequently Overemphasized

771

Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies Original Research Article

772

Drug-Eluting Stent Thrombosis: Results From the Multicenter Spanish Registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos) Original Research Article

773

Drug-Eluting Stent-Induced Left Anterior Descending Coronary Artery Aneurysm: Repair by Pericardial Patch—Where Are We Headed?

774

Drug-Eluting Stent-Induced Vascular Dysfunction: Common and Missing Links

775

Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus: The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent I

776

Drug-Eluting Stenting for Unprotected Left Main Coronary Artery Disease: Are We Ready to Replace Bypass Surgery?

777

Drug-Eluting stents

778

Drug-Eluting Stents “Next Generation” Basic Science Workshop

779

Drug-eluting stents 1— preclinical

780

Drug-eluting stents 2-economics and cost effectiveness

781

Drug-eluting stents 3-restenosis following stenting with drug-eluting stents

782

Drug-eluting stents 4-paclitaxel, everolimus, and other agents

783

Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: Combination therapy for the future

784

Drug-Eluting Stents and Late Adverse Clinical Outcomes: Lessons Learned, Lessons Awaited

785

Drug-eluting stents and late stent thrombosis

786

Drug-Eluting Stents and the Future of Coronary Artery Bypass Surgery: Facts and Fiction

787

Drug-Eluting Stents Are Safe and Effective: Right or Wrong?

788

Drug-Eluting Stents for Acute Myocardial Infarction

789

Drug-eluting stents for coronary artery disease: A review

790

Drug-Eluting Stents for Critical Limb Ischemia

791

Drug-eluting stents for diabetes mellitus: A rush to judgment? Review Article

792

Drug-Eluting Stents for Saphenous Vein Graft Lesions: The Limits of Evidence

793

Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stents

794

Drug-eluting stents in diabetics & Complex patient groups

795

Drug-Eluting Stents in Heart Transplant Recipients

796

Drug-Eluting Stents in the Treatment of Intermediate Lesions: Pooled Analysis From Four Randomized Trials Original Research Article

797

Drug-eluting stents in total coronary occlusions: Another piece of the puzzle solved?

798

Drug-eluting stents in vascular intervention

799

Drug-Eluting Stents Versus Bare Metal Stents for Narrowing in Saphenous Vein Grafts

800

Drug-Eluting Stents Versus Bare Metal Stents in Percutaneous Coronary Interventions (A Meta-Analysis)

801

Drug-Eluting Stents Versus Bilateral Internal Thoracic Grafting for Multivessel Coronary Disease

802

Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus

803

Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels

804

Drug-eluting stents, 5-sirolimus stents and oral rapamycin

805

Drug-eluting stents: A multidisciplinary success story

806

Drug-eluting stents: an innovative multidisciplinary drug delivery platform

807

Drug-eluting stents: Beyond the hyperbole

808

Drug-eluting stents: Factors governing local pharmacokinetics

809

Drug-eluting stents: Failures and restenosis

810

Drug-eluting stents: insights into safety and indications

811

Drug-eluting stents: is new necessarily better?

812

Drug-Eluting Stents: Is Their Future as Bright as Their Past?

813

Drug-eluting stents: Lesion subsets

814

Drug-Eluting Stents: Life Insurance With a Better Death Benefit

815

Drug-eluting stents: Miscellaneous

816

Drug-eluting stents: Patient and lesion subsets

817

Drug-eluting stents: Registries and trials

818

Drug-eluting stents: Registries and trials

819

Drug-eluting stents: results, promises and problems

820

Drug-eluting stents: some bare facts

821

Drug-Eluting Versus Bare Metal Stents for Saphenous Vein Graft Intervention

822

Drug-evaluation harmonisation will lead to fewer animal tests

823

Drug-exposed infant cases in juvenile court: risk factors and court outcomes

824

Drug-Facilitated Effects on Protective Airway Reflexes During Out-of-Hospital Endotracheal Intubation

825

Drug-free in vitro activation and autologous transplantation in infertile women with diminished ovarian reserve: An experimental pilot study

826

Drugging Drug Resistance

827

Drugging the Bad “AKT-TOR” to Overcome TKI-Resistant Lung Cancer

828

Drugging the Undruggable

829

Drug–GSH interaction on GSH–Au modified electrodes: A cyclic voltammetry and electrochemical impedance spectroscopy study

830

Drug-hormone interactions on neurobehavioral responses in human neonates

831

Drug-induced Acute Interstitial Nephritis Pathology, Pathogenesis, and Treatment

832

Drug-induced amnesia impairs implicit relational memory

833

Drug-induced and toxic myopathies

834

Drug-Induced Apnea in Children Admitted to Loghman Hakim Hospital, Tehran, Iran

835

Drug-induced atrial fibrillation Review Article

836

Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug Original Research Article

837

Drug-induced autoimmunity

838

Drug-Induced Brugada Syndrome in Children: Clinical Features, Device-Based Management, and Long-Term Follow-Up

839

Drug-Induced Bullous Pemphigoid: Rapid Resolution with Corticosteroid Therapy

840

Drug-Induced by Systemic Lupus Erythematosus Presenting as Recurrent Pericardial Effusion After Mitral Valve Repair

841

Drug-induced cholestasis

842

Drug-induced gingival overgrowth and its tentative pharmacotherapy

843

Drug-Induced Gingival Overgrowth in an 8-Year-Old Girl: A Case Report

844

Drug-induced headaches

845

Drug-induced headaches

846

Drug-induced heart failure

847

drug-induced hemophagocytosis

848

Drug-induced hepatocellular liver injury due to benzylpenicillin with evidence of lymphocyte sensitization

849

Drug-induced hyperkalemia

850

Drug-induced hyperkalemia: old culprits and new offenders

851

Drug-induced hyperkalemia: The reply:

852

Drug-Induced Hypersensitivity Syndrome (DRESS) by Phenobarbital - Case Report and Literature Review

853

Drug-Induced Hypersensitivity Syndrome Caused by Carbamazepine Used for the Treatment of Trigeminal Neuralgia

854

Drug-induced interstitial nephritis in a child with idiopathic nephrotic syndrome

855

Drug-Induced Lichen Planus

856

Drug-Induced Linear Immunoglobulin-A Bullous Dermatosis

857

Drug-induced liver diseases

858

Drug-induced liver injury following positive drug rechallenge

859

Drug-Induced Long QT Syndrome and Exome Sequencing: Chinese Shadows Link Past and Future

860

Drug-Induced Lupus Erythematosus

861

Drug-induced lupus erythematosus

862

Drug-induced methemoglobinemia during thoracoscopic lung biopsy

863

Drug-induced myocardial infarction in young patients: Report of two cases

864

Drug-induced Nephrotoxicity and Medicinal Plants

865

Drug-induced neurological disorders : by K.K. Jain, 1996, Hogrefe & Huber Publishers, Seattle, USA, 389 pages, US$ 79, ISBN 0-88937-154-7

866

Drug-Induced Pemphigoid:: Bullous and Cicatricial

867

Drug-Induced Pemphigus

868

Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine

869

Drug-Induced QT Interval Prolongation and Torsade De Pointes:Identification of Risk Factors

870

Drug-induced renal disorders

871

Drug-Induced Scleroderma and Sclerodermiform Conditions

872

Drug-induced stabilisation of a mismatched C-T base pair in a DNA hairpin

873

Drug-induced systemic lupus erythematosus and TNF-α blockers

874

Drug-induced systemic lupus erythematosus and TNF-α blockers

875

Drug-induced systemic lupus erythematosus and TNF-α blockers

876

Drug-induced systemic lupus erythematosus associated with etanercept therapy

877

Drug-induced torsades de pointes in one patient with congenital long QT syndrome

878

Drug-Induced Toxic Epidermal Necrolysis

879

Drug-induced tremors

880

DRUG-INDUCED VASCULITIS IN A BREAST CANCER PATIENT RECEIVING CHEMOTHERAPY

881

Drug–lactose binding aspects in adhesive mixtures: Controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces

882

Drug-licensing anomalies and Parkinsonʹs disease

883

Drug-loaded chondroitin sulfate-based nanogels: Preparation and characterization

884

Drug-loaded electrospun nanofibrous sheets as barriers against postsurgical adhesions in mice model

885

Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells

886

Drug-lunch alert

887

Drugmaker seeks permissions to collaborate on Cuban vaccine

888

Drug–protein interactions assessed by fluorescence measurements in the real complexes and in model dyads

889

Drug-related Death low Registration in Iran: A Mixed Method Approach for Causes, Recommendations to Solve This Problem and Geographical Evaluation of an Intervention

890

Drug-related deaths by region, sex, and age group per 100 injecting drug users in Scotland, 2000–01

891

Drug-related killings: a case of mistaken identity Review Article

892

Drug-related problems (DRPs) identified from geriatric medication safety review clinics

893

Drug-related Problems Among Type 2 Diabetic Patients With Hypertension in a Tertiary Care Hospital in Lebanon: A Cross-sectional Study

894

Drug‑related Problems in Hypertensive Patients: A Cross‑sectional Study from Indonesia

895

Drug-related Problems in Solid-Organ Transplant Recipients Hospitalized for COVID-19: An Experience of a Referral Tertiary Center in Iran

896

Drug-Resistance Associated Mutations in Polymerase (P) Gene of Hepatitis B Virus Isolated From Malaysian HBV Carriers

897

Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

898

Drug-resistant enteric fever in the UK

899

Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome

900

Drug-resistant genotyping in HIV-1 therapy

901

Drug-resistant genotyping in HIV-1 therapy

902

Drug-resistant genotyping in HIV-1 therapy

903

Drug-resistant genotyping in HIV-1 therapy

904

Drug-resistant genotyping in HIV-1 therapy

905

Drug-resistant gonorrhoeae spread in the USA

906

Drug-Resistant Phosphatidylinositol 3-Kinase: Guidance for the Preemptive Strike

907

Drug-resistant Pneumocystis carinii

908

Drug-Resistant Proteus Virulence Factors Characterization and Their Inhibition Using Probiotic Bacteria

909

Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome

910

Drug-resistant strains of HIV increase sharply in Japan

911

Drug-resistant Streptococcus pneumoniae: rational antibiotic choices

912

Drug-resistant tuberculosis

913

Drug-Resistant Tuberculosis and Group 5 Anti-Tuberculosis Drugs

914

Drug-resistant tuberculosis in Taipei, 1996-1999

915

Drug-resistant tuberculosis: desperate measures?

916

Drugs & devices in brief

917

Drugs against superbugs: private lessons from bacteriophages

918

Drugs and a dark future

919

Drugs and Addictive Behaviour: A Guide to Treatment (3rd edition): Hamid Ghodse, Cambridge University Press 2002. £39.95, 520 pages

920

Drugs and demons

921

Drugs and mental health

922

Drugs and narcotics in history : Edited by Roy Porter and Mikulas Teich. Cambridge University Press, Cambridge, 1995. xii + 227 pp., U.S.$49.95 (cloth)

923

Drugs and nutrition: how side effects can influence nutritional intake

924

Drugs and nutrition: Important drug-nutrient interactions

925

Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea

926

Drugs and pests: intertemporal production externalities

927

Drugs and Pharmacology for Nurses, 12th edn, S.J. Hopkins. Churchill Livingstone (1995), ISBN: 0-443-05249-2

928

Drugs and risk-taking in tourism

929

Drugs and the art of Fred Tomaselli

930

Drugs and the immune system: the emerging era of immunopharmacology

931

Drugs deaths drop in Switzerland

932

Drugs elevating extracellular adenosine enhance cell cycling of hematopoietic progenitor cells as inferred from the cytotoxic effects of 5-fluorouracil

933

Drugs Expiration Date Dilemma!

934

Drugs for Left Ventricular Remodeling in Heart Failure

935

Drugs for obstetric conditions

936

Drugs for the gynecologist to prescribe in the prevention of breast cancer: Current status and future trends

937

Drugs for vascular dementia

938

Drugs in Exacerbation and Provocation of Psoriasis

939

Drugs in Nursing Practice: C R Henney, RJ Dow, A M Macconnachie Churchill Livingstone, 1995, 5th edn ISBN 0-443-05235-2, 482 pages Price £12.95

940

Drugs in Pregnancy and Lactation, Sixth Edition: Gerald G. Briggs, Roger K. Freeman, & Sumner J.Yaffe. ISBN 0-7817-3203-4, Lippincott Williams & Wilkins, Philadelphia, 2002, 1595 pp

941

Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources – a review

942

Drugs in the Plant

943

Drugs in the postgenomic era

944

Drugs Induced Alzheimer’s Disease in Animal Model

945

Drugs lose out to revascularisation in symptom-free coronary disease

946

DRUGS MINIMIZING BLOOD LOSS DURING LIVER TRANSPLANTATION

947

Drugs of Abuse and Alcohol in Weekend Drivers Involved in Car Crashes in Belgium, , ,

948

Drugs of Abuse and Immuno-Modulation

949

Drugs of abuse and reward comparison: a brief review

950

Drugs of abuse and the elicitation of human aggressive behavior

951

Drugs of abuse in oral fluid collected by two different sample kits – Stability testing and validation using ultra performance tandem mass spectrometry analysis

952

Drugs of abuse in pregnancy

953

Drugs of abuse in urban groundwater. A case study: Barcelona Original Research Article

954

Drugs or Implantable Cardioverter-Defibrillators in Patients with Poor Left Ventricular Function?

955

Drugs Prescribed by Dentists in Fars Province, Iran

956

Drugs solubilization in ascorbyl–decanoate micellar solutions

957

958

Drugs Used in Pregnancy

959

Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action

960

Drugs, diet and disease

961

Drugs, HIV Treatment and Harm Reduction Services for Afghan Refugees in Iran

962

Drugs, leads, and drug-likeness: an analysis of some recently launched drugs

963

DRUGS-FACILITATED STREET AND TRAVEL RELATED CRIMES: A NEW PUBLIC HEALTH ISSUE

964

Drug-testing practices in US hotels

965

Drug-trial “irregularities” uncovered in Argentina

966

Drug-trial compensation demands in lreland

967

Drug-use behavior and correlates in people with schizophrenia

968

Drug-use initiation and conduct disorder among adolescents in drug treatment

969

Druid wins Baan contract with Weston Aerospace

970

Drum agglomeration behavior of nickel laterite ore: Effect of process variables

971

Drum granulation of NPK fertilizers

972

Drum leaching tests in iron removal from quartz using oxalic and sulphuric acids

973

Drum Sound Recognition for Polyphonic Audio Signals by Adaptation and Matching of Spectrogram Templates With Harmonic Structure Suppression

974

Drum-boiler dynamics

975

Drum-like silencers using magnetic forces in a pressurized cavity

976

977

Drunk drivers in the courts: Legal and extra-legal factors affecting pleas and sentences

978

Drunk driving and mental disorders

979

Drunk driving and mental disorders

980

Drunk, but not blind: The effects of alcohol intoxication on change blindness

981

Drupangtonine, a novel antileukemic alkaloid from Cephalotaxus harringtonia var. drupacea

982

Drushbametrics — My Russian adventures

983

Dry aging of beef in a bag highly permeable to water vapour

984

Dry air effects on the copper oxides sensitive layers formation for ethanol vapor detection

985

Dry anaerobic digestion of food waste under mesophilic conditions: Performance and methanogenic community analysis

986

Dry and lubricated wear resistance of mechanically-alloyed aluminium-base sintered composites

987

Dry and semi-dry machining using finely crystallized diamond coating cutting tools

988

Dry and Wet Abrasive Conditions of Fe-C-B Wear Resistance Hardfacing Alloy on Mild Steel

989

Dry and wet abrasive resistance of Inconel 600 and stellite

990

Dry and wet atmospheric deposition of nitrogen and phosphorus in Singapore

991

Dry and wet deposition of elemental carbon on a tropical forest in Thailand

992

Dry and wet deposition of elements in Hong Kong

993

Dry and wet deposition of mercury near a chlor-alkali plant

994

Dry and wet deposition of nutrients from the tropical Atlantic atmosphere: Links to primary productivity and nitrogen fixation

995

Dry and wet deposition of water-insoluble dust and water-soluble chemical species during spring 2007 in Tsukuba, Japan

996

Dry and wet rainy seasons in the Mantaro river basin (Central Peruvian Andes)

997

Dry and wet sliding wear of ITO-coated PET components used in flexible optoelectronic applications

998

Dry and Wet Wear Characteristic of TiO2 Thin Film Prepared by Magnetic Sputtering in Ringer Solution

999

Dry ashing of organic rich matrices with palladium for the determination of arsenic using inductively coupled plasma-mass spectrometry Original Research Article

1000

Dry atmospheric deposition and deposition velocities of dicamba, 2,4-dichlorophenoxyacetic acid and γ-1,2,3,4,5,6-hexachlorocyclohexane Original Research Article

بازگشت